Study at a glance
What was studied?
This review compares five studies of human T cells, immune cells that help direct responses. Researchers grew cells in the laboratory. Some came from healthy blood donors and others from inflamed rheumatoid joints. They tested active vitamin D hormone or a form that cells could convert into hormone.
What was found?
The cells could acquire characteristics associated with restraint, but other signals and local conversion mattered. Cells from inflamed rheumatoid joints were less sensitive to some effects. In one study, measured cell expansion was greater than in similar cultures not given active hormone at day four, but relevant division measures were lower than that comparison at day seven.
What does it mean?
Vitamin D can change T-cell behaviour under particular conditions. A measured cell protein is a clue to activity, not proof of a lasting function that restrains other immune responses. Short laboratory responses do not establish lasting immune memory.
What are the limits?
Samples were small, and several studies shared investigators. Laboratory exposure to calcitriol, the active vitamin D hormone, differs from taking vitamin D3. The studies did not show that supplements prevent autoimmune disease, which involves inappropriate responses against the body’s own material, or create lasting restraint of such responses. They did not establish a personal dose.
Read the full article below ↓Vitamin D signalling can change how activated T cells develop and regulate other immune responses. The evidence does not support one permanent, uniformly suppressive T-cell state. Human-cell experiments instead show dependence on accompanying signals, local vitamin D activation, prior differentiation and the time of measurement. These findings explain mechanisms of adaptive regulation; they do not establish that supplements create lasting immune tolerance in people. Read the shorter counterpart, Vitamin D, T-Cell Differentiation and Regulatory Balance: Study Summary.
The question: a change in cell fate, or a change in one measurement?
T cells help the immune system recognise particular targets and coordinate responses. Differentiation is the process through which activated cells acquire more specialised patterns of activity. Some produce signals that support inflammation. Others help restrain responses. The studies considered here chiefly concern human CD4 T cells, which coordinate other immune cells. They should not be treated as a complete account of every T-cell lineage, especially CD8 cells that can kill infected cells.
The physiological setting is Vitamin D and Adaptive Immunity. The narrower question here is whether vitamin D changes the acquisition of inflammatory or regulatory characteristics, how those changes were tested, and what can be inferred about tolerance. A protein commonly found on regulatory cells is not by itself proof that a cell has acquired a stable regulatory identity. A short suppression assay adds functional information but still does not establish years of self-tolerance.
Five primary experimental programmes provide complementary evidence: conditional regulatory induction, precursor availability, a distinct regulatory cytokine programme, disease-site resistance and time-dependent proliferation. Several share investigators. They are distinct experiments, not five independent laboratories confirming a clinical benefit. Most use small, assay-specific donor sets. Numbers of cells or replicate wells must not be mistaken for numbers of people. [1] [2] [3] [4] [5]
Which form of vitamin D reached the cells?
Cholecalciferol is vitamin D3 used in many supplements. The circulating precursor 25-hydroxyvitamin D3 is also called calcifediol. Calcitriol, or 1,25-dihydroxyvitamin D3, is the active hormone. The vitamin D receptor, abbreviated VDR, helps cells respond to that hormone. The enzyme CYP27B1 converts the precursor to calcitriol. [2] [3]
These distinctions matter experimentally. Adding calcitriol directly to cultured cells bypasses the need for precursor uptake and conversion. Adding precursor asks an additional question about cellular metabolism. A person’s blood 25-hydroxyvitamin D concentration does not directly report the active-hormone exposure of each T cell. The broader metabolism is described in Local Activation of Vitamin D in Non-Classical Target Tissues: Full Study; the experiments here test particular local arrangements rather than a universal blood threshold.
The principal studies commonly used active hormone at 10 or 100 nanomoles per litre. These concentrations describe culture methods. They cannot be converted into a recommended oral dose, nor assumed to reproduce tissue exposure after ordinary supplementation. Exposure duration, binding proteins and activation conditions differ between cultures and living people. [1] [2] [3] [4] [5]
Regulatory characteristics depended on accompanying signals
Jeffery and colleagues’ 2009 study activated healthy-donor CD4 cells using defined laboratory signals, with either activation beads or supporting monocytes. Calcitriol reduced production of several inflammatory cytokines, including interferon-gamma, interleukin-17 and interleukin-21, under the tested conditions. Cytokines are signals used by cells to communicate. The treatment increased interleukin-10 and the regulatory checkpoint protein CTLA-4. [1]
The response was more specific than a general halt to activation. Entry into division was not obviously suppressed in the bead-driven system. Furthermore, induction of FoxP3, a protein associated with regulatory T cells, depended importantly on interleukin-2 and the culture setting. Calcitriol alone did not give every activation system the same regulatory phenotype. The accompanying survival and activation signals formed part of the mechanism being tested.
Importantly, the researchers also tested function. Cells conditioned with calcitriol and interleukin-2 had greater capacity to restrain responder-cell activity in a short laboratory assay. This goes beyond noting a marker change. It supports an acquired regulatory capacity under those conditions, while leaving open its stability, antigen specificity and behaviour in tissues. Regulatory markers after a single stimulation were not indefinitely maintained. [1]
The detailed checkpoint relationship is covered in Vitamin D, CTLA-4 and Immune Restraint: Full Study. Here its significance is that differentiation cannot be inferred from one marker alone. FoxP3, CTLA-4, cytokine release and suppression of a responder are related but separate observations. None of these short experiments measured whether a person stopped reacting to a self-antigen or avoided an autoimmune diagnosis. That larger question belongs to Vitamin D and Immune Tolerance.
Precursor access changed the regulatory response
The 2012 follow-on study examined how 25-hydroxyvitamin D3 became available to antigen-presenting cells. These cells help activate T cells by displaying material they have encountered. In the tested co-cultures, dendritic cells could convert precursor and support changes in T-cell regulatory and inflammatory readouts. T cells activated with beads alone responded much less effectively to precursor under that protocol. Direct active hormone remained a different exposure. [2]
This finding locates an important condition between blood supply and cellular response. A precursor must be available to the cells, converted, and delivered in an activation setting that permits a response. Vitamin-D-binding protein restricted precursor availability in these cultures. Exploratory genotype comparisons did not establish a clinically useful test, an optimal concentration of free vitamin D or a treatment strategy.
The FoxP3 experiments also supplied transforming growth factor-beta and interleukin-2. Their presence prevents the result from being described as vitamin D alone determining regulatory fate. The investigators used several approaches, including conversion measurements, conditioned medium and inhibition, to examine the local mechanism. These approaches support a role for cellular metabolism without making each pharmacological intervention perfectly selective. [2]
An additional quantitative limit matters: the paper corrected certain stored-metabolite measurements for degradation, referring to a supplementary validation. This review does not use those corrected values to claim a precise conversion yield. The useful conclusion is qualitative and conditional: precursor access and antigen-presenting-cell context can alter the T-cell response. The experiment does not show that every T cell is unable to activate vitamin D.
A regulatory programme need not be conventional FoxP3 differentiation
Chauss and colleagues tested another activation context involving complement-related CD46 signalling. Their human-cell experiments supported induction of VDR and CYP27B1 and a local vitamin-D-dependent change in activated type-1 helper T cells. Measured outputs shifted away from inflammatory cytokines and towards interleukin-10. Perturbing components of the proposed pathway weakened the response. [3]
This differs from the precursor-limited bead cultures in the 2012 study. Different activation conditions can change the metabolic machinery available to a T cell. The papers therefore should not be compressed into either “T cells always make their own active vitamin D” or “only dendritic cells can activate it.” Each describes a particular experimental system. Their comparison is useful precisely because it exposes the missing conditions in either universal statement.
Nor did the Chauss cells simply become conventional FoxP3 regulatory T cells. The programme involved interleukin-6, its receptor and STAT3 signalling in supporting interleukin-10 induction. Interleukin-6 increased rather than uniformly falling. Its contribution depended on the rest of the programme; interleukin-6 without vitamin D did not reproduce the same effect. [3]
This is relevant to Vitamin D and Cytokine Balance: the meaning of a cytokine cannot be assigned solely from its name. An increase in one signal may contribute to restraint in one setting without being beneficial in every disease. The study’s secondary COVID-19 datasets were observational. They did not test supplementation as treatment, and they do not turn a cellular regulatory programme into evidence of clinical recovery.
Previously differentiated cells were not equally responsive
The rheumatoid-joint study by Jeffery and colleagues tested a major limitation of healthy-donor experiments. The investigators compared cells from blood and inflamed joint fluid, with additional purified-cell experiments. Patient-derived cells had already experienced disease, local inflammation and treatment. They were not interchangeable with newly activated healthy blood cells. [4]
Some inflammatory populations from joint fluid were less sensitive to calcitriol than blood-derived populations. The result was not uniform across cytokines or cell types. Established inflammatory characteristics were harder to change than their initial acquisition. Comparisons involving naive and memory cells also differed by endpoint; it would be inaccurate to call every memory T cell resistant or every interleukin-17 response unchanged.
The study thus qualifies a simple conversion story. A signal that influences an initially developing response may have a smaller effect once a cell has acquired a committed inflammatory programme in a tissue. The observations do not identify a single proven molecular cause of resistance. Measured receptor-related expression did not supply a simple explanation based only on less receptor. [4]
Small, varying patient samples, medication exposure and short culture limit generalisation. No randomized oral treatment comparison was performed. The results cannot establish either that supplementation treats rheumatoid arthritis or that it never helps any patient. They show why differentiation state and tissue origin must remain visible when assessing regulatory mechanisms.
Proliferation and memory markers require their own interpretation
Vera and colleagues’ 2026 experiments add a temporal qualification. In activated human CD4-cell cultures exposed to calcitriol, measured expansion was greater than in carrier-treated comparison cultures at day four, whereas relevant division and expansion indices were lower than carrier at day seven. Glutamine-related experiments supported a metabolic contribution; adding glutamine later partially improved subsequent expansion compared with vitamin D alone. This did not demonstrate restoration of normal immune protection. [5]
The early increase matters because regulatory cytokine changes do not imply that every aspect of T-cell activity falls. Cell number, division, inflammatory output and regulatory function are different outcomes. A single time point can miss a change in direction. The separate question of response magnitude and trajectory is considered through Vitamin D and Immune Modulation; it should not be confused with proof of durable lineage change.
A higher frequency of cells bearing a central-memory marker pattern at an early culture time was not a demonstration of antigen-specific memory lasting after re-exposure. This distinction is developed in Vitamin D and Immune Memory. Likewise, the experiments do not establish stronger vaccine protection, fewer infections or slower age-related immune change. Vitamin D and Immune Ageing concerns that separate physiological question. The present experiments measured short laboratory responses, not those long-term outcomes.
The study used small donor sets, and its pathway-enrichment analysis was explicitly exploratory, accepting a false-discovery-rate threshold as high as 0.6 before biological curation. That is not stringent confirmation of every proposed metabolic pathway. The observed temporal response and selected functional perturbations deserve more weight than an expansive mechanistic narrative based on exploratory enrichment alone. [5]
What the combined evidence establishes
| Evidence level | Supported interpretation | Boundary |
|---|---|---|
| Regulatory markers and short suppression assays | Conditional regulatory characteristics can develop | Stable self-tolerance was not demonstrated |
| Precursor and local-activation experiments | Cellular context changes hormone availability and response | No universal serum target follows |
| Joint-derived cells | Existing inflammatory state can limit responsiveness | No clinical treatment comparison was performed |
| Early and later proliferation | Direction can depend on time and endpoint | Memory phenotype is not lasting protection |
Together, these studies support conditional regulation of activated CD4-cell differentiation and behaviour. They also show why immune restraint, tolerance and memory require different measurements. Related investigators and potentially overlapping donor sources reduce claims of external replication; multiple assays within one programme are not multiple independent studies.
The strongest conclusion is mechanistic: vitamin D signalling can influence regulatory and inflammatory characteristics under specified conditions. The evidence does not establish a universal permanent T-cell switch, a clinical tolerance mechanism for every autoimmune disease, or a supplement regimen that reproduces these culture results. Keeping the activation context, vitamin D form, cell state and observation time explicit preserves what the experiments actually add.
Primary sources
[1] Jeffery LE et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. Journal of immunology (Baltimore, Md. : 1950). 2009;183(9):5458-5467. DOI: 10.4049/jimmunol.0803217. PMID: 19843932.
[2] Jeffery LE et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-5164. DOI: 10.4049/jimmunol.1200786. PMID: 23087405.
[3] Chauss D et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3. PMID: 34764490.
[4] Jeffery LE et al. Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint. Journal of autoimmunity. 2018;88:50-60. DOI: 10.1016/j.jaut.2017.10.001. PMID: 29066221.
[5] Vera AA et al. Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis. Frontiers in immunology. 2026;17:1791098. DOI: 10.3389/fimmu.2026.1791098. PMID: 42367775.
Related reading
Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
1,25(OH)2D3 had significantly less suppressive effect on Th17 cells (IL-17+IFNγ-) and Th17.1 cells (IL-17+IFNγ+) from SF compared to those from blood, and had no effect on SF CD4+ or CD8+ IFNγ+ T cell frequencies.
Original paper ↗Read more →Vitamin D, T-Cell Differentiation and Regulatory Balance: Study Summary
Plain-English summary of human T-cell studies: vitamin D responses and why laboratory regulation does not prove lasting immune tolerance.
Read more →Vitamin D, Cell Fate and Tissue Structure: Study Summary
A plain-English summary of vitamin D, cell differentiation and tissue structure, including contrasting findings and the limits of human evidence.
Read more →Betaine promotes cell differentiation of human osteoblasts in primary culture
The possible effects of BET on hObs differentiation were evaluated by real time PCR, western blot and immunofluorescence analysis.
Original paper ↗Read more →Metformin and vitamin D modulate adipose-derived stem cell differentiation towards the beige phenotype
In the present paper, we aimed at evaluating the effect of metformin and vitamin D in targeting ADSC differentiation towards an intermediate phenotype, as beige adipocytes.
Original paper ↗Read more →Metformin and Vitamin D Modulate Inflammation and Autophagy during Adipose-Derived Stem Cell Differentiation
In the present paper we aimed to evaluate the role of metformin and vitamin D, alone or in combination, in modulating inflammation and autophagy in ADSCs during adipogenic commitment.
Original paper ↗Read more →Skewed epithelial cell differentiation and premature aging of the thymus in the absence of vitamin D signaling
Central tolerance of thymocytes to self-antigen depends on the medullary thymic epithelial cell (mTEC) transcription factor autoimmune regulator (Aire), which drives tissue-restricted antigen (TRA) gene expression.
Original paper ↗Read more →Vitamin D Effects on Cell Differentiation and Stemness in Cancer
Vitamin D3 is the precursor of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), a pleiotropic hormone that is a major regulator of the human genome.
Original paper ↗Read more →Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids
We also investigated the effects of 1α,25-dihydroxyvitamin D3 (calcitriol) on differentiation.
Original paper ↗Read more →Vitamin D Promotes Remyelination by Suppressing c-Myc and Inducing Oligodendrocyte Precursor Cell Differentiation after Traumatic Spinal Cord Injury
The impact on myelin integrity was examined by transmission electron microscopy and studied in vitro using primary culture of oligodendrocytes.
Original paper ↗Read more →Vitamin D and Cell Differentiation
Vitamin D influences cell differentiation by interacting with gene expression, epigenetic mechanisms, and signalling pathways.
Read more →Vitamin D, Cell Fate and Tissue Structure: Full Evidence Review
How vitamin D signalling changes cell fate in selected cell and animal studies, and what those changes can show and cannot establish about tissue function.
Read more →Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T‐cell expansion
In this study, we investigated the therapeutic effects of vitamin D receptor activation by calcitriol on PD, specifically focusing on its role in Treg.
Original paper ↗Read more →Vitamin D, B-Cell Function and the Limits of Immune Memory Evidence: Full Evidence Review
A review of B-cell experiments and vaccine trials, separating memory-cell markers and antibody changes from lasting protection against infection.
Read more →Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon?
Here, we investigated the relationship between serum 25-hydroxyvitamin D (25(OH)D) level and T cell differentiation in chronic HD patients.
Original paper ↗Read more →Implications of vitamin D for flesh quality of grass carp (Ctenopharyngodon idella): antioxidant ability, nutritional value, sensory quality, and myofiber characteristics
Here, the influence of dietary vitamin D on fillet quality, antioxidant ability, and myofiber development was examined in grass carp (Ctenopharyngodon idella).
Original paper ↗Read more →Mechanistic Effects of Calcitriol in Cancer Biology
In the context of cancer, calcitriol regulates the cell cycle, induces apoptosis, promotes cell differentiation and acts as anti-inflammatory factor within the tumor microenvironment.
Original paper ↗Read more →Niemann-Pick Type A Disease: Behavior of Neutral Sphingomyelinase and Vitamin D Receptor
Sphingomyelinase (SMase) is responsible for the breakdown of sphingomyelin (SM) with production of ceramide.
Original paper ↗Read more →Restored expression of vitamin D receptor and sensitivity to 1,25-dihydroxyvitamin D3 in response to disrupted fusion FOP2-FGFR1 gene in acute myeloid leukemia cells
Acute myeloid leukemia (AML) cells can be induced to undergo terminal differentiation with subsequent loss of tumorigenicity using 1,25-dihydroxyvitamin D3 (1,25D) alone or in combination with hematopoietic cytokines.
Original paper ↗Read more →The anti-aging effect of vitamin D and vitamin D receptor in Drosophila midgut
In this study, we aimed to determine the protective role of the vitamin D/vitamin D receptor pathway in differentiated enterocytes (ECs) during intestinal stem cell (ISC) aging.
Original paper ↗Read more →Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Original paper ↗Read more →Original sources
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3
Published in Journal of immunology (Baltimore, Md. : 1950) (2009).
Publication details
[1] Jeffery LE et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. Journal of immunology (Baltimore, Md. : 1950). 2009;183(9):5458-5467. DOI: 10.4049/jimmunol.0803217. PMID: 19843932.
Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses
Published in Journal of immunology (Baltimore, Md. : 1950) (2012).
Publication details
[2] Jeffery LE et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-5164. DOI: 10.4049/jimmunol.1200786. PMID: 23087405.
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
Published in Nature immunology (2022).
Publication details
[3] Chauss D et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3. PMID: 34764490.
Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
1,25(OH)2D3 had significantly less suppressive effect on Th17 cells (IL-17+IFNγ-) and Th17.1 cells (IL-17+IFNγ+) from SF compared to those from blood, and had no effect on SF CD4+ or CD8+ IFNγ+ T cell frequencies.
Publication details
[4] Jeffery LE et al. Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint. Journal of autoimmunity. 2018;88:50-60. DOI: 10.1016/j.jaut.2017.10.001. PMID: 29066221.
Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis
Published in Frontiers in immunology (2026).
Publication details
[5] Vera AA et al. Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis. Frontiers in immunology. 2026;17:1791098. DOI: 10.3389/fimmu.2026.1791098. PMID: 42367775.